AMN Healthcare
AMN
Market cap $808M

21.16 USD

-0.94

4.25%

At close Jul 11, 4:00 PM EDT

After hours

21.25

+0.09

0.43%

1 day

-4.25%

5 days

-1.35%

1 month

-4.04%

3 months

10.73%

6 months

-23.36%

Year to date

-13.81%

1 year

-57.10%

5 years

-53.57%

10 years

-33.58%

About: AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.

Employees: 2,968

Healthcare Medical Care Facilities

0

Funds holding %

of 7,312 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

38% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 39

32% more repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 84

14% more call options, than puts

Call options by funds: $4.65M | Put options by funds: $4.06M

4% more funds holding

Funds holding: 273 [Q4 2024] → 285 (+12) [Q1 2025]

3% more capital invested

Capital invested by funds: $946M [Q4 2024] → $972M (+$26M) [Q1 2025]

0.19% more ownership

Funds ownership: 103.82% [Q4 2024] → 104.01% (+0.19%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$25

18%

upside

Avg. target

$25

19%

upside

High target

$26

21%

upside

2 analyst ratings

1 positive

50%

1 neutral

50%

0 negative

0%

UBS A.J. Rice	21%upside $26	Neutral Maintained	13 May 2025
Truist Securities Tobey Sommer	18%upside $25	Buy Maintained	15 Apr 2025

See Analyst Rankings

Financial journalist opinion

Based on 10 articles about AMN published over the past 30 days

AMN Healthcare to Hold Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025

DALLAS, July 10, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its second quarter 2025 financial results and third quarter 2025 outlook on Thursday, August 7, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.

AMN Healthcare to Hold Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025

Zacks Investment Research

AMN Stock Gains Post Latest Deals With symplr to Boost Operations

AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.

AMN Stock Gains Post Latest Deals With symplr to Boost Operations

AMN Is Cheap After The Sale Of Symplr

AMN Healthcare is undervalued, trading below $900 million market cap, with strong free cash flow and recent strategic moves to reduce net debt. The sale of Symplr and board expertise in M&A position AMN for further portfolio optimization and potential value-unlocking transactions. Despite recent goodwill impairments and cautious analyst outlooks, AMN's financial initiatives and management actions could attract renewed investor interest.

AMN Is Cheap After The Sale Of Symplr

symplr Acquires AMN Healthcare's Smart Square Scheduling Software, Enhancing AI-Driven Workforce Optimization for Health Systems

Strengthening symplr's commitment to helping providers optimize staffing, operations, and outcomes HOUSTON , July 2, 2025 /PRNewswire/ -- symplr® , a leading provider of enterprise healthcare operations software backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and Charlesbank Capital Partners LLC (together with its affiliates, "Charlesbank"), has acquired the Smart Square® scheduling software from AMN Healthcare (NYSE: AMN).

symplr Acquires AMN Healthcare's Smart Square Scheduling Software, Enhancing AI-Driven Workforce Optimization for Health Systems

AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions

Strategic Partnership Fosters Integration, Innovation in Healthcare Workforce Planning & Management Strategic Partnership Fosters Integration, Innovation in Healthcare Workforce Planning & Management

AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions

Zacks Investment Research

What Makes AMN Healthcare (AMN) a New Buy Stock

AMN Healthcare (AMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

What Makes AMN Healthcare (AMN) a New Buy Stock

Zacks Investment Research

Does AMN Healthcare (AMN) Have the Potential to Rally 29.32% as Wall Street Analysts Expect?

The consensus price target hints at a 29.3% upside potential for AMN Healthcare (AMN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Does AMN Healthcare (AMN) Have the Potential to Rally 29.32% as Wall Street Analysts Expect?

Zacks Investment Research

Should Value Investors Buy AMN Healthcare Services (AMN) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy AMN Healthcare Services (AMN) Stock?

Celia Huber Joins AMN Healthcare Board of Directors

DALLAS, June 24, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, announced the election of Celia Huber to its Board of Directors during its annual meeting of shareholders on May 2, 2025. Huber's background includes more than 30 years of experience advising healthcare systems, public and private sector payors and companies on strategy, risk and performance.

Celia Huber Joins AMN Healthcare Board of Directors

AMN Healthcare: Demand For Therapy And Imaging Specialties, And Undervalued

AMN Healthcare is undervalued, trading at 3.02x FWD cash flow, with strong demand in therapy and imaging specialties supporting future growth. AI investments and normalization post-COVID-19 are expected to enhance service offerings and drive free cash flow improvements in the coming years. Debt reduction has lowered interest expenses, and a large stock repurchase program signals management's confidence in the company's intrinsic value.

AMN Healthcare: Demand For Therapy And Imaging Specialties, And Undervalued

See News Rankings

Charts implemented using Lightweight Charts™